Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01EG02	EVEROLIMUS BIOGARAN	G	Everolimus - 10mg	10mg	Tablet	L.L
A02BC01	ULCAZAL	G	Omeprazole (sodium) - 40mg	40mg	Injectable sterile lyophilised powder for solution	5,916,747 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
C03DA04	HEPERONA 50	G	Eplerenone - 50mg	50mg	Tablet, coated	2,150,148 L.L
C09CA04	IRBAVEL 150	G	Irbesartan - 150mg	150mg	Tablet, film coated	564,414 L.L
C10AA05	ATORVASTATINE ARROW GENERIQUES	G	Atorvastatin - 80mg	80mg	Tablet, coated	564,414 L.L
D10AD01	AVOTIN-A	G	Tretinoin - 0.05%	0.05%	Cream	440,780 L.L
G04BE08	DURALIS 5	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,791,790 L.L
L01EG02	EVEROLIMUS BIOGARAN	G	Everolimus - 10mg	10mg	Tablet	124,701,632 L.L
M01AE03	HUMFINE	G	Ketoprofen - 100mg/2ml	100mg/2ml	Injectable solution	3,514,148 L.L
N02AX02	TRAMADOL NORMON	G	Tramadol HCl - 100mg/2ml	100mg/2ml	Injectable solution	169,324 L.L
N06AB10	APO-ESCITALOPRAM	G	Escitalopram (oxalate) - 10mg	10mg	Tablet	565,758 L.L
R02AA20	ANGINOVA	G	Lidocaine HCl - 1mg, Dequalinium HCl - 0.25mg		Lozenge	349,399 L.L
R06AX26	EXOFEN	G	Fexofenadine HCl - 180mg	180mg	Tablet, film coated	287,582 L.L
L01EF01	PAPILLIO	G	Palbociclib - 125mg	125mg	Capsule, hard	L.L
A02BC01	OMEPRAL	G	Omeprazole - 20mg	20mg	Powder for suspension	712,876 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
C09CA04	IRBESARTAN ARROW	G	Irbesartan - 150mg	150mg	Tablet	470,345 L.L
C10AA05	TARDELIP	G	Atorvastatin - 80mg	80mg	Tablet, film coated	1,055,876 L.L
D10AD01	KETREL	G	Tretinoin - 0.05%	0.05%	Cream	397,777 L.L
G04BE08	ENKOR	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,766,193 L.L
J01MA12	EVOXIL HELLAS	G	Levofloxacin - 500mg/100ml	500mg/100ml	Injectable solution	959,504 L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 2.5mg	2.5mg	Tablet	57,802,039 L.L
N06AB10	CITOLES	G	Escitalopram (oxalate) - 10mg	10mg	Tablet, film coated	511,940 L.L
R06AX26	FENADEX 180	G	Fexofenadine HCl - 180mg	180mg	Tablet, film coated	295,645 L.L
A02BC01	OMEPRAL	G	Omeprazole - 10mg	10mg	Powder for suspension	890,776 L.L
A11A	BEBE-VIT	G	Vitamin A - 1500IU/ml, Vitamin D3 - 400IU/ml, Vitamin E - 5mg/ml, Vitamin C - 40mg/ml, Vitamin B1 - 0.5mg/ml, Vitamin B2 - 0.6mg/ml, Vitamin B6 - 0.6mg/ml, Nicotinamide - 8mg/ml		Drops	287,582 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
C04AD03	PENTOXIFYLLINE SR	G	Pentoxifylline - 1160	400mg	Tablet, sustained release	1,478,227 L.L
C09CA04	ZIOREL	G	Irbesartan - 150mg	150mg	Tablet, film coated	575,933 L.L